Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Betamethasone dipropionate
Drug ID BADD_D00261
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01637
MeSH ID C011175
PubChem ID 21800
TTD Drug ID Not Available
NDC Product Code 22552-0028; 49452-1075; 65089-0009; 16714-996; 45802-376; 50090-5232; 0472-0381; 45802-505; 66993-897; 68788-9219; 71205-275; 72578-093; 0713-0659; 0168-0057; 0168-0265; 50090-4679; 63629-8613; 63629-9323; 63629-9324; 70518-3562; 68788-7241; 0472-0380; 70518-3701; 0713-0807; 38779-0017; 0168-0268; 45802-021; 51407-273; 70771-1380; 78206-124; 51927-0171; 50090-2182; 53002-8280; 63187-286; 68788-7670; 50090-0235; 51672-1309; 51672-1390; 63629-8614; 68462-290; 70710-1233; 70771-1550; 50090-4680; 51672-1340; 68071-2850; 68788-9804; 0472-0382; 51672-1274; 51672-1310; 51552-0022; 52128-160; 0168-0055; 0168-0056; 50090-1839; 51672-1317; 68040-714; 68180-947; 68788-0382; 46439-8710; 0168-0267; 50090-0236
UNII 826Y60901U
Synonyms betamethasone-17,21-dipropionate | betamethasone dipropionate | Diprosone | Diprolene | Beloderm | betamethasone propionate | Maxivate | augmented betamethasone dipropionate
Chemical Information
Molecular Formula C28H37FO7
CAS Registry Number 5593-20-4
SMILES CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrophy08.03.04.001---
Blister12.01.06.002; 23.03.01.001---
Burning sensation08.01.09.029; 17.02.06.001---
Cushing's syndrome05.01.01.001; 14.11.01.007; 19.07.03.002; 24.08.04.001---
Dermatitis23.03.04.002---
Dermatitis acneiform23.02.01.004--
Dermatitis contact10.01.01.003; 12.03.01.040; 23.03.04.004---
Dry skin23.03.03.001--
Erythema23.03.06.001---
Folliculitis11.02.01.053; 23.11.04.003--
Glycosuria20.02.01.005--
Hyperaesthesia17.02.06.004; 23.03.03.080---
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hypertension24.08.02.001--
Hypertrichosis23.02.04.002--
Infection11.01.08.002---
Leukoderma23.05.02.001---
Miliaria23.02.03.014---
Pain08.01.08.004--
Papule23.03.03.038---
Paraesthesia17.02.06.005; 23.03.03.094--
Pruritus23.03.12.001--
Rash erythematous23.03.13.029---
Rash follicular23.03.10.001---
Skin atrophy23.01.05.001--
Skin depigmentation23.05.02.002---
Skin disorder23.03.03.007---
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009---
Skin striae23.01.05.002---
The 1th Page    1 2    Next   Last    Total 2 Pages